Article Information
History
- September 9, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Rita Székely, PhD1,
- Bianca Sossen, MBChB2,3,
- Madalo Mukoka, MSc4,5,
- Monde Muyoyeta, PhD6,
- Elizabeth Nakabugo, BSc7,
- Jerry Hella, PhD8,
- Hung Van Nguyen, PhD9,
- Sasiwimol Ubolyam, PhD10,
- Kinuyo Chikamatsu, BSc11,
- Aurélien Macé, PhD1,
- Marcia Vermeulen, MBChB3,
- Chad M Centner, MSc12,
- Sarah Nyangu, MBChB6,
- Nsala Sanjase, MBChB6,
- Mohamed Sasamalo, MSc8,
- Huong Thi Dinh, MSc9,
- The Anh Ngo, PhD13,
- Weerawat Manosuthi, MD14,
- Supunnee Jirajariyavej, MD15,
- Satoshi Mitarai, MD11,
- Nhung Viet Nguyen, PhD9,
- Anchalee Avihingsanon, PhD10,
- Klaus Reither, PhD16,17,
- Lydia Nakiyingi, PhD7,
- Andrew D. Kerkhoff, MD18,
- Peter MacPherson, PhD4,19,20,
- Graeme Meintjes, PhD2,3,
- Claudia M Denkinger, MD1,21,22,*,
- Morten Ruhwald, PhD1,*,†,
- FujiLAM Study Consortium**
- 1FIND, the global alliance for diagnostics, Geneva, Switzerland
- 2Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
- 3Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
- 4Public Health Group, Malawi-Liverpool-Wellcome Programme, Blantyre, Malawi
- 5Department of Pathology, Kamuzu University of Health Sciences, Blantyre, Malawi
- 6Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
- 7Infectious Diseases Institute, Makerere University, Kampala, Uganda
- 8Ifakara Health Institute, Dar es Salaam, Tanzania
- 9National Lung Hospital, Ha Noi, Viet Nam
- 10HIV-NAT, Thai Red Cross AIDS Research Centre and Centre of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 11Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Japan
- 12Division of Medical Microbiology, University of Cape Town and National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa
- 13Viet Tiep Hospital, Hai Phong, Viet Nam
- 14Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
- 15Taksin Hospital, Bangkok, Thailand
- 16Swiss Tropical and Public Health Institute, Allschwil, Switzerland
- 17University of Basel, Basel, Switzerland
- 18Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, CA
- 19Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
- 20Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom
- 21Division of Infectious Disease and Tropical Medicine, Heidelberg University Hospital and Faculty of Medicine, Heidelberg University, Heidelberg, Germany
- 22German Centre for Infection Research (DZIF), Partner site Heidelberg University Hospital, Heidelberg, Germany
- ↵†Corresponding author: Morten Ruhwald, morten.ruhwald{at}finddx.org, Campus Biotech Chemin des Mines 9 1202 Geneva, Switzerland, M +41 (0)79 911 65 35
- 23FIND, Geneva, Switzerland
- 24FIND, Hanoi, Viet Nam
- 25Centre for Infectious Diseases research in Zambia, Lusaka, Zambia
- 26HIV-NAT, Thai Red Cross AIDS Research Centre and Excellent center in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 27Hai Phong University of Medicine and Pharmacy, Hai Phong, Viet Nam
- 28Hai Phong Lung Hospital, Hai Phong, Viet Nam
↵* These authors contributed equally
Contributors RS, BS, MMo, JH, HVN, KR, LN, ADK, GM, CMD designed the study; RS, BS, MMo, JH, HVN, SU, TAN, WM, SJ, NVN, AA, KR, LN, ADK, PMP, GM, CMD and MR oversaw the study. BS, MMa, MMo, EN, JH, SU, MV, SN, NS, MS, HTD, LN, PMP, GM coordinated the individual study sites. SM oversaw and KC coordinated the post-hoc laboratory study. Statistical analysis was undertaken by AM. The manuscript drafts were developed by RS, CMD and MR and TU with input from the authors. All authors contributed to interpretation of data and editing of the article and approved the final version of the manuscript. Authors under the FujiLAM study consortium contributed to the individual phases of the study such as study design, coordination, data analysis and interpretation.
Posted September 09, 2022.
Multicentre accuracy trial of FUJIFILM SILVAMP TB LAM test in people with HIV reveals lot variability
